Cytarabine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Cytarabine and local guidelines before prescribing.

Antimetabolite cytotoxic

Mechanism

Pyrimidine antimetabolite.

Uses

Acute myeloid leukaemia, lymphoma, meningeal leukaemia (intrathecal).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Marrow suppression, cerebellar toxicity, conjunctivitis, fever, rash.

Interactions

Digoxin absorption reduced.

Contraindications and cautions

Severe marrow suppression

Monitoring

FBC, LFT, neurology

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce dose in renal and hepatic impairment

Overdose and reversal

Supportive

Special advice

Steroid eye drops with high doses; neurological checks.

More from the textbook: uses, cautions and other points
Where it is discussed in the book